AstraZeneca to invest $2 billion as part of US manufacturing push

Core Viewpoint - AstraZeneca plans to invest $2 billion to expand its manufacturing capabilities in Maryland as part of a broader $50 billion initiative to enhance manufacturing and research in the U.S. by 2030 [1] Investment Plans - The $2 billion investment is a significant step in AstraZeneca's strategy to bolster its manufacturing footprint in the United States [1] - This investment is part of a larger commitment of $50 billion aimed at expanding both manufacturing and research capabilities by the year 2030 [1]